Trial Details
COMPLETEDBasic Information
| Clinical ID | c62 |
|---|---|
| Identifier | NCT03043677 |
| Trial Title | Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | BIOLOGICAL: Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab |
Participant Information
| Sponsor | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2016-04-01 |
|---|---|
| Primary Completion Date | 2017-12-31 |
| Completion Date | 2018-05-30 |